Clinical Study

Epidemiological Study of Uveal Melanoma from US Surveillance, Epidemiology, and End Results Program (2010–2015)

Table 3

Univariate analysis of overall and disease-specific survival (1142 cases included).

Characteristic value for log rankCumulative survival rate at 5 y, %
OSDSSOSDSS

Overall61.866.5
Age rangea
 YoungReferenceReference71.468.9
 Mid0.0010.79861.072.6
 Elder<0.0010.0131.959.7
Sex
 FemaleReferenceReference62.968.0
 Male0.1660.37960.865.2
Race
 WhiteReferenceReference60.265.5
 Others0.0420.04984.491.1
Origin
 HispanicReferenceReference57.666.7
 Non-Hispanic0.2120.14361.261.4
Laterality
 RightReferenceReference60.267.9
 Left0.6980.47561.765.2
AJCC stage
 IReferenceReference88.093.6
 II<0.001<0.00167.472.9
 III<0.001<0.00146.349.5
 IV<0.001<0.00113.7b14.4 b
Summary stage
 LocalizedReferenceReference64.369.3
 Regional0.0130.0260.163.4
 Distant<0.001<0.00113.5b11.2 b
Metastasis at diagnosis
 NoneReferenceReference62.667.4
 Distant<0.001< 0.00113.5b11.2 b
Surgery
 PerformedReferenceReference54.759.5
 Not performed<0.001<0.00167.371.8
Radiation
 PerformedReferenceReference69.074.2
 Not performed<0.001<0.00152.655.3
Chemotherapy
 PerformedReferenceReference56.056.0
 Not performed0.1600.05961.366.8
Marital status
 MarriedReferenceReference62.166.1
 Others0.8240.6161.467.1

Abbreviations: OS, overall survival; DSS, disease-specific survival; AJCC, American Joint Committee on Cancer. aAge stratification was different in OS and DSS, according to results of X-tile process. bDue to lack of patient sample, the longest follow-up time was 46 months. We used the latest survival data instead of accurate 5-year accumulative survival rate. Bold letter indicates that measurements are statistically significant compared with references () ; ; .